Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model

作者: Robin de Vries , Mirjam Kretzschmar , Joop F. P. Schellekens , Florens G. A. Versteegh , Tjalke A. Westra

DOI: 10.1371/JOURNAL.PONE.0013392

关键词:

摘要: BACKGROUND: Despite widespread immunization programs, a clear increase in pertussis incidence is apparent many developed countries during the last decades. Consequently, additional strategies are considered to reduce burden of disease. The aim this study design an individual-based stochastic dynamic framework model transmission population order predict epidemiologic and economic consequences implementation universal booster vaccination programs. Using framework, we estimate cost-effectiveness adolescent at age 12 years Netherlands. METHODS/PRINCIPAL FINDINGS: We designed discrete event simulation (DES) epidemiological implementing vaccination. used national age-specific notification data over period 1996-2000--corrected for underreporting--to calibrate assuming steady state situation. Subsequently, was introduced. Input parameters were derived from literature, sources (e.g. costing data, hospitalization data) expert opinions. As there no consensus on duration immunity acquired by natural infection, two scenarios protection (i.e. 8 15 years). In both scenarios, total decreased as result From societal perspective, estimated €4418/QALY (range: 3205-6364 € per QALY) €6371/QALY 4139-9549 8- 15-year respectively. Sensitivity analyses revealed that outcomes most sensitive quality life weights CONCLUSIONS/SIGNIFICANCE: To our knowledge first population. This indicates likely be cost-effective intervention suited investigate further strategies.

参考文章(72)
Schellekens Jfp, Melker He de, Greeff Sc de, Mooi Fr, Pertussis in the Netherlands 2001-2002 Rijksinstituut voor Volksgezondheid en Milieu RIVM. ,(2004)
Deborah A. Sadowski, Randall P. Sadowski, David W. Kelton, Simulation with Arena ,(1998)
William Hollingworth, D. Eldon Spackman, Emerging methods in economic modeling of imaging costs and outcomes a short report on discrete event simulation. Academic Radiology. ,vol. 14, pp. 406- 410 ,(2007) , 10.1016/J.ACRA.2007.01.007
Robert M. May, Roy M. Anderson, Infectious Diseases of Humans: Dynamics and Control ,(1991)
Paul E. M. Fine, Herd Immunity: History, Theory, Practice Epidemiologic Reviews. ,vol. 15, pp. 265- 302 ,(1993) , 10.1093/OXFORDJOURNALS.EPIREV.A036121
Jeffrey P. Koplan, Stephen C. Schoenbaum, Milton C. Weinstein, David W. Fraser, Pertussis Vaccine — An Analysis of Benefits, Risks and Costs New England Journal of Medicine. ,vol. 301, pp. 906- 911 ,(1979) , 10.1056/NEJM197910253011703
Michael Iskedjian, Thomas R. Einarson, Bernie J. O??Brien, J. Gaston De Serres, Ron Gold, Ian M. Gemmill, Natalie Milkovich, Andrew Rosner, Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada PharmacoEconomics. ,vol. 19, pp. 551- 563 ,(2001) , 10.2165/00019053-200119050-00009
R. Shaikh, D. Guris, P. M. Strebel, M. Wharton, Underreporting of pertussis deaths in the United States: need for improved surveillance. Pediatrics. ,vol. 101, pp. 323- 323 ,(1998) , 10.1542/PEDS.101.2.323
Frank Kowalzik, Arnaldo Prata Barbosa, Vera Regina Fernandes, Paulo Roberto Carvalho, Mar??a Luisa Avila-Aguero, Daniel Y. T. Goh, Anne Goh, M Jesus Garcia de Miguel, Fernando Moraga, Joan Roca, Magda Campins, Li Ming Huang, Jorge Quian, Nicole Riley, Dominique Beck, Thomas Verstraeten, Prospective multinational study of pertussis infection in hospitalized infants and their household contacts. Pediatric Infectious Disease Journal. ,vol. 26, pp. 238- 242 ,(2007) , 10.1097/01.INF.0000256750.07118.EE